SNCA and Parkinson disease: Both TLR2 and TLR4, whose expression levels are increased in PD patients and MPTP-administrated models, can be activated by α-Synuclein to induce sterile inflammation in PD (Kaur et al., 2017; Ferreira and Romero-Ramos, 2018).